Maureen Early

Maureen Early has held various roles in the pharmaceutical industry since 1994, beginning as a Sr. Product Manager, Anti-infectives at Rhone-Poulenc Rorer. Maureen then moved to Aventis in 1996 as Director of Oncology Marketing. In 2000, they took on the role of President at Upside Endeavors, followed by Vice President, Commercial at Synthetic Biologics, Inc. in 2015. Most recently, in 2017, they joined The iTero Group as Principal and is currently VP Commercial at Rénibus Therapeutics Inc.

Maureen Early attended Marywood University, followed by Saint Joseph's University, where they earned a Master of Business Administration (MBA) in International Business.